WA
KYNB

WFG Advisors’s Kyntra Bio KYNB Stock Holding History

WFG Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$5K Buy
+6
New +$4.18K ﹤0.01% 1277

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WFG Advisors's KYNB Position: Q2 2017 in Review

WFG Advisors opened a new position in Kyntra Bio (KYNB) in Q2 2017: 6 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #1277 among its holdings.

151 funds tracked by Wall St. Rank hold KYNB as of Q2 2017.

  • WFG Advisors held 6 shares of Kyntra Bio worth $5K as of Q2 2017.
  • Kyntra Bio was a new WFG Advisors position in Q2 2017.
  • Kyntra Bio made up ﹤0.01% of WFG Advisors's portfolio in Q2 2017, its #1277 holding.
  • 151 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.